CME Webast Teaches On Chronic Kidney Disease. Now, dialysis has become so commonplace that we now consider it to be a routine treatment in nearly every hospital in the country. But more importantly, we now have treatments that can hold kidney failure in check and often prevent the need for dialysis. Today on MedNet, we are going to take a look at some of these new developments in the management of chronic kidney disease. I’m please to introduce today’s guest. Dr. Khaled Boubes is nephrologist and Assistant Professor of Internal Medicine at the Ohio State University.
View a video introduction of this webcast
What you’ll learn in this webcast
As a result of this educational activity, webcast participants will be able to: recognize the prevalence and importance of CKD; and realize the importance and effectiveness of SGLT2-inhibitors in halting the progression of CKD.
You’ll also learn about the following:
- Causes of chronic kidney disease
- New treatments for chronic kidney disease
- Diet and chronic kidney disease
- Blood pressure management in chronic kidney disease
- Anti-hypertensive medication selection in chronic kidney disease
- Acute dialysis indications
- Chronic dialysis indications
- Options for dialysis
You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.